These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analgesic synergy between topical opioids and topical non-steroidal anti-inflammatory drugs in the mouse model of thermal pain. Kolesnikov Y; Sõritsa D Eur J Pharmacol; 2008 Jan; 579(1-3):126-33. PubMed ID: 18001710 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the tail formalin test in mice as a new model to assess local analgesic effects. Kolesnikov Y; Cristea M; Oksman G; Torosjan A; Wilson R Brain Res; 2004 Dec; 1029(2):217-23. PubMed ID: 15542077 [TBL] [Abstract][Full Text] [Related]
4. Analgesic synergy between topical morphine and butamben in mice. Kolesnikov YA; Cristea M; Pasternak GW Anesth Analg; 2003 Oct; 97(4):1103-1107. PubMed ID: 14500165 [TBL] [Abstract][Full Text] [Related]
5. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist. Kolesnikov Y; Pasternak GW J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783 [TBL] [Abstract][Full Text] [Related]
6. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration. Cichewicz DL; McCarthy EA J Pharmacol Exp Ther; 2003 Mar; 304(3):1010-5. PubMed ID: 12604676 [TBL] [Abstract][Full Text] [Related]
7. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception. Williams J; Haller VL; Stevens DL; Welch SP Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663 [TBL] [Abstract][Full Text] [Related]
8. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats. Hernández-Delgadillo GP; Cruz SL Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138 [TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
10. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Kögel B; Christoph T; Strassburger W; Friderichs E Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189 [TBL] [Abstract][Full Text] [Related]
11. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids. Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089 [TBL] [Abstract][Full Text] [Related]
12. Interaction of intrathecally infused morphine and lidocaine in rats (part I): synergistic antinociceptive effects. Saito Y; Kaneko M; Kirihara Y; Sakura S; Kosaka Y Anesthesiology; 1998 Dec; 89(6):1455-63. PubMed ID: 9856720 [TBL] [Abstract][Full Text] [Related]
13. Isobolographic analysis of caramiphen and lidocaine on spinal anesthesia in rats. Chen YW; Chu CC; Chen YC; Wang JJ; Hung CH Neurosci Lett; 2010 Jan; 469(1):174-8. PubMed ID: 19962431 [TBL] [Abstract][Full Text] [Related]
14. Analgesic synergism between intrathecal morphine and cyclooxygenase-2 inhibitors in mice. Pinardi G; Prieto JC; Miranda HF Pharmacol Biochem Behav; 2005 Sep; 82(1):120-4. PubMed ID: 16102800 [TBL] [Abstract][Full Text] [Related]
15. Local anesthetics potentiate spinal morphine antinociception. Akerman B; Arweström E; Post C Anesth Analg; 1988 Oct; 67(10):943-8. PubMed ID: 3421498 [TBL] [Abstract][Full Text] [Related]
16. Spinal synergy between nonselective cyclooxygenase inhibitors and morphine antinociception in mice. Miranda HF; Prieto JC; Pinardi G Brain Res; 2005 Jul; 1049(2):165-70. PubMed ID: 15936732 [TBL] [Abstract][Full Text] [Related]
17. Topical methadone and meperidine analgesic synergy in the mouse. Kolesnikov YA; Oksman G; Pasternak GW Eur J Pharmacol; 2010 Jul; 638(1-3):61-4. PubMed ID: 20433826 [TBL] [Abstract][Full Text] [Related]
18. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception. Fischer BD; Dykstra LA J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537 [TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL; Bartlett JL; Ananthan S; Bilsky EJ J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048 [TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of localized administration of opioids compared with lidocaine. Hassan HG; Pilcher CW; Akerman B; Renck H Reg Anesth; 1989; 14(3):138-44. PubMed ID: 2577247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]